nafamostat has been researched along with dactinomycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gunji, Y; Kanai, N; Kashii, Y; Momoi, MY; Odaka, J; Saito, M; Yamauchi, T | 1 |
1 other study(ies) available for nafamostat and dactinomycin
Article | Year |
---|---|
Refractory kaposiform hemangioendothelioma that expressed vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3: a case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Benzamidines; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Guanidines; Hemangioendothelioma; Humans; Immunohistochemistry; Infant; Interferon-alpha; Magnetic Resonance Imaging; Male; Oleic Acids; Platelet Transfusion; Prednisolone; Prognosis; Sclerosing Solutions; Sclerotherapy; Soft Tissue Neoplasms; Thrombocytopenia; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3; Vincristine | 2009 |